Neurocognition in the psychosis risk syndrome: A quantitative and qualitative Review

Current Pharmaceutical Design

Volumn 18, Issue 4, 2012, Pages 399-415

  Giuliano, Anthony J ^a   Li, Huijun ^a,b   Mesholam Gately, Raquelle I ^a   Sorenson, Shannon M ^c   Woodberry, Kristen A ^a   Seidman, Larry J ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b FLORIDA A AND M UNIVERSITY   (United States)

^c UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Clinical high risk; Meta analysis; Neurocognition; Prodrome; Psychosis; Schizophrenia

Indexed keywords

ALERTNESS; ARTICLE; ATTENTION; COGNITION; COGNITIVE DEFECT; COMORBIDITY; EXECUTIVE FUNCTION; HUMAN; LANGUAGE; MEMORY; MOTOR PERFORMANCE; PHENOTYPE; PRIORITY JOURNAL; PSYCHOSIS; PSYCHOSIS RISK SYNDROME; SCHIZOPHRENIA; SMELLING; SOCIAL COGNITION; WORKING MEMORY;

CLINICAL TRIALS AS TOPIC; COGNITION DISORDERS; DISEASE PROGRESSION; HUMANS; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIC PSYCHOLOGY; SYNDROME;

EID: 84863070557     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212799316019     Document Type: Article

References (95)

1. Klosterkotter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001; 58(2): 158-64.
2. McGlashan TH, Walsh BC, Woods SW. The psychosis-risk syndrome: handbook for diagnosis and follow-up. New York Oxford University Press, Inc.; 2010.
3. McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry 2006; 40(8): 616-22.
4. Woods SW, Addington J, Cadenhead KS, et al. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull 2009; 35(5): 894-908.
5. Yung AR MP. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull 1996; 22(2): 353-70.
6. Yung AR, McGorry PD. The initial prodrome in psychosis: descriptive and qualitative aspects. Aust N Z J Psychiatry 1996; 30(5): 587-99.
7. Cornblatt BA, Lencz T, Smith CW, Correll CU, Auther AM, Nakayama E. The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophr Bull 2003; 29(4): 633-51.
8. Walker E, Mittal V, Tessner K. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu Rev Clin Psychol 2008; 4: 189-216.
9. Cannon TD. Neurodevelopment and the transition from schizophrenia prodrome to schizophrenia: research imperatives. Biol Psychiatry 2008; 64(9): 737-8.
10. Insel TR. Translating scientific opportunity into public health impact: a strategic plan for research on mental illness. Arch Gen Psychiatry 2009; 66(2): 128-33.
11. Addington J. The promise of early intervention. Early Intervention in Psychiatry 2007; 1: 294-307.
12. Insel TR. The arrival of preemptive psychiatry. Early Intervention in Psychiatry 2007; 1 5-6.
13. McGorry PD, Nelson B, Amminger GP, et al. Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry 2009; 70(9): 1206-12.
14. Kraepelin E. Dementia praecox and paraphrenia. Robertson G, editor. Chicago: Chicago: Medical Book Company; 1919.
15. Bleuler E. Dementia praecox or the group of schizophrenias. Oxford England: International Universities Press; 1950.
16. Pantelis C, Yucel M, Bora E, et al. Neurobiological markers of illness onset in psychosis and schizophrenia: the search for a moving target. Neuropsychol Rev 2009; 19(3): 385-98.
17. Seidman LJ, Giuliano AJ, Meyer EC, et al. Neuropsychology of the prodrome to psychosis in the NAPLS Consortium: relationship to family history and conversion to psychosis. Arch Gen Psychiatry 2010; 67 (6): 578-88.
18. Harvey PD, & Keefe, RSE Clinical neuropsychology of schizophrenia. In: I Grant KA, editor. Neuropsychological assessment of neuropsychiatric and neuromedical disorders. 3 ed. New York: Oxford University Press; 2009. p. 507-22.
19. Seidman LJ, Cassens G, Kremen WS, Pepple JR. The neuropsychology of schizophrenia. In: White RF, editor. Clinical syndromes in adult neuropsychology: the practitioners handbook. New York: Elsevier; 1992. p. 381-450.
20. Malla A, Payne J. First-episode psychosis: psychopathology, quality of life, and functional outcome. Schizophr Bull 2005; 31(3): 650-71.
21. Niendam TA, Bearden CE, Johnson JK, et al. Neurocognitive performance and functional disability in the psychosis prodrome. Schizophr Res 2006; 84(1): 100-11.
22. Niendam TA, Bearden C, Zinberg J, Johnson JK, O'Brien M, Cannon TD. The course of neurocognition and social functioning in individuals at ultra high risk for psychosis. Schizophr Bull 2007; 33(3): 772-81.
23. Pantelis C, Velakoulis D, McGorry PD, et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003; 361(9354): 281-8.
24. Sun D, Phillips L, Velakoulis D, et al. Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr Res 2009 Mar; 108(1-3): 85-92.
25. Takahashi T, Wood SJ, Yung AR, et al. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis. Arch Gen Psychiatry 2009; 66(4): 366-76.
26. Snitz BE, Macdonald AW, Carter CS. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a metaanalytic review of putative endophenotypes. Schizophr Bull 2006; 32(1): 179-94.
27. Seidman LJ, Giuliano AJ, Smith CW, et al. Neuropsychological functioning in adolescents and young adults at genetic risk for schizophrenia and affective psychoses: results from the Harvard and Hillside Adolescent High Risk Studies. Schizophr Bull 2006; 32(3): 507-24.
28. Woodberry KA, Giuliano AJ, Seidman LJ. Premorbid IQ in schizophrenia: a meta-analytic review. Am J Psychiatry 2008; 165(5): 579-87.
29. Cornblatt B, Obuchowski M, Roberts S, Pollack S, Erlenmeyer- Kimling L. Cognitive and behavioral precursors of schizophrenia. Dev Psychopathol 1999; 11(3): 487-508.
30. Davidson M, Reichenberg A, Rabinowitz J, Weiser M, Kaplan Z, Mark M. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am J Psychiatry 1999; 156(9): 1328-35.
31. Murray RM, Lewis SW. Is schizophrenia a neurodevelopmental disorder?. Br Med J 1987; 295: 681-2.
32. Reichenberg A, Weiser M, Rabinowitz J, et al. A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder. Am J Psychiatry 2002; 159(12): 2027-35.
33. Schiffman J, Walker E, Ekstrom M, Schulsinger F, Sorensen H, Mednick S. Childhood videotaped social and neuromotor precursors of schizophrenia: a prospective investigation. Am J Psychiatry 2004; 161(11): 2021-7.
34. Tarbox SI, Pogue-Geile M. Development of social functioning in preschizophrenia children and adolescents: a systematic review. Psychol Bull 2008; 134(4): 561-83.
35. Walker E ST, David, D. Neuromotor precursors of schizophrenia. Schizophr Bull 1994; 20: 441-52.
36. Walker EF. Developmentally moderated expressions of the neuropathology underlying schizophrenia. Schizophr Bull 1994; 20(3): 453-80.
37. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987; 44(7): 660-9.
38. Walker E, Shapiro D, Esterberg M, Trotman H Neurodevelopment and schizophrenia: broadening the focus. Current Directions in Psychological Science 2010; 19: 204-8.
39. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998; 12(3): 426-45.
40. Mesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV, Seidman LJ. Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology 2009; 23(3): 315-36.
41. Aleman A, Hijman R, de Haan EHF, Kahn RS. Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry 1999; 156(9): 1358-66.
42. Dickinson D, Ramsey ME, Gold JM. Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Arch Gen Psychiatry 2007; 64(5): 532-42.
43. Henry JD, Crawford JR. A meta-analytic review of verbal fluency deficits in schizophrenia relative to other neurocognitive deficits. Cognit Neuropsychiatry 2005; 10(1): 1-33.
44. Knowles EEM, David AS, Reichenberg A. Processing speed in schizophrenia: reexamining the evidence. American Journal of Psychiatry 2010; 167: 828-35.
45. Lencz T, Smith CW, McLaughlin D, et al. Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biol Psychiatry 2006 May 1; 59(9): 863-71.
46. Woodberry KA, Seidman LJ, Giuliano AJ, Verdi MB, Cook WL, McFarlane WR. Neuropsychological profiles in individuals at clinical high risk for psychosis: relationship to psychosis and intelligence. Schizophr Res 2010; 123(2-3): 188-98.
47. Brewer WJ, Wood SJ, Phillips LJ, et al. Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis. Schizophr Bull 2006; 32(3): 538-55.
48. Wolf FM. Meta-analysis: quantitative methods for research synthesis. Newbury Park, CA: Sage; 1986.
49. Chapman LJ, Chapman JP, Kwapil TR, Eckblad M, Zinser MC. Putatively psychosis-prone subjects 10 years later. J Abnorm Psychol 1994; 103(2): 171-83.
50. Hedges LV, Olkin I. Statistical methods for meta-analysis. Orlando: Academic Press, Inc.; 1985.
51. Jahshan C, Heaton RK, Golshan S, Cadenhead KS. Course of neurocognitive deficits in the prodrome and first episode of schizophrenia. Neuropsychology 2010; 24(1): 109-20.
52. Eastvold AD, Heaton RK, Cadenhead KS. Neurocognitive deficits in the (putative) prodrome and first episode of psychosis. Schizophr Res 2007; 93(1-3): 266-77.
53. Becker HE, Nieman DH, Wiltink S, et al. Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration? Psychol Med 2010; 40(10): 1599-606.
54. Becker HE, Nieman DH, Dingemans PM, van de Fliert JR, De Haan L, Linszen DH. Verbal fluency as a possible predictor for psychosis. Eur Psychiatry 2010; 25(2): 105-10.
55. Keefe RS, Perkins DO, Gu H, Zipursky RB, Christensen BK, Lieberman JA. A longitudinal study of neurocognitive function in individuals at-risk for psychosis. Schizophr Res 2006; 88(1-3): 26-35.
56. Miller TJ, McGlashan TH, Woods SW, et al. Symptom assessment in schizophrenic prodromal states. Psychiatr Q 1999; 70(4): 273-87.
57. Yung A. Identification of the population. In: Addington J, editor. Working with people at high risk of developing psychosis Hoboken, NJ: John Wiley & Sons 2006. p. 7-23.
58. Schultze-Lutter F. Subjective symptoms of schizophrenia in research and the clinic: the basic symptom concept. Schizophr Bull 2009; 35(1): 5-8.
59. Klosterkötter J RS, Schultze-Lutter F, et al. The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe. World Psychiatry 2005; 4(3): 161-7.
60. Simon AE, Dvorsky DN, Boesch J, et al. Defining subjects at risk for psychosis: a comparison of two approaches. Schizophr Res 2006; 81(1): 83-90.
61. Cannon TD CK, Cornblatt B, et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Archives of General Psychiatry 2008; 65(1): 28-37.
62. Klosterkotter J HM, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001; 58(2): 158-64.
63. Yung AR, Stanford C, Cosgrave E, et al. Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophr Res 2006; 84(1): 57-66.
64. Faraone SV, Seidman LJ, Kremen WS, Pepple JR, Lyons MJ, Tsuang MT. Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: a diagnostic efficiency analysis. J Abnorm Psychol 1995; 104(2): 286-304.
65. SPSS I. SPSS 18.0 Command Syntax Reference Chicago, ILL: SPSS Inc; 2010.
66. StataCorp. Stata: Release 9. College Station, TX: StataCorp; 2005.
67. Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, Inc.; 1988.
68. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7(3): 177-88.
69. Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997; 315(7109): 629-34.
70. Smith CW, Park S, Cornblatt B. Spatial working memory deficits in adolescents at clinical high risk for schizophrenia. Schizophr Res 2006; 81(2-3): 211-5.
71. Dickinson D, Gold JM. Less unique variance than meets the eye: overlap among traditional neuropsychological dimensions in schizophrenia. Schizophr Bull 2008; 34(3): 423-34.
72. Miyake A, Friedman NP, Emerson MJ, Witzki AH, Howerter A, Wager TD. The unity and diversity of executive functions and their contributions to complex Frontal Lobe tasks: a latent variable analysis. Cogn Psychol 2000; 41(1): 49-100.
73. Brewer WJ, Wood SJ, McGorry PD, et al. Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. Am J Psychiatry 2003; 160(10): 1790-4.
74. Strauss E, Sherman E, Spreen O. A compendium of neuropsychological tests 3ed. New York: Oxford; 2006.
75. Brewer WJ, Francey SM, Wood SJ, et al. Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Am J Psychiatry 2005; 162(1): 71-8.
76. Hawkins KA, Addington J, Keefe RS, et al. Neuropsychological status of subjects at high risk for a first episode of psychosis. Schizophr Res 2004; 67(2-3): 115-22.
77. Pflueger MO, Gschwandtner U, Stieglitz RD, Riecher-Rossler A. Neuropsychological deficits in individuals with an at risk mental state for psychosis - working memory as a potential trait marker. Schizophr Res 2007; 97(1-3): 14-24.
78. Gschwandtner U, Pfluger M, Aston J, et al. Fine motor function and neuropsychological deficits in individuals at risk for schizophrenia. Eur Arch Psychiatry Clin Neurosci 2006; 256(4): 201-6.
79. Pinkham AE, Penn DL, Perkins DO, Graham KA, Siegel M. Emotion perception and social skill over the course of psychosis: a comparison of individuals at-risk for psychosis and individuals with early and chronic schizophrenia spectrum illness. Cogn Neuropsychiatry 2007; 12(3): 198-212.
80. Addington J, Penn D, Woods SW, Addington D, Perkins D. Facial affect recognition in individuals at clinical high risk for psychosis. British J of Psychiatry 2008; 192: 67-8.
81. Chung YS, Kang DH, Shin NY, Yoo SY, Kwon JS. Deficit of theory of mind in individuals at ultra-high-risk for schizophrenia. Schizophr Res 2008; 99(1-3): 111-8.
82. Szoke A, Trandafir A, Dupont ME, Meary A, Schurhoff F, Leboyer M. Longitudinal studies of cognition in schizophrenia: metaanalysis. Br J Psychiatry 2008; 192(4): 248-57.
83. Reichenberg A, Caspi A, Harrington H, et al. Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30- year study. Am J Psychiatry 2010; 167(2): 160-9.
84. Carter CS, Barch D. Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative. Schizophr Bull 2007; 33 (5): 1131-7.
85. Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol 2010; 6: 109-38.
86. Yung AR, Phillips LJ, Yuen HP. Psychosis prediction: 12-month follow up of a high-risk (prodromal) group. Schizophr Res 2003; 60: 21-32.
87. Yung AR, Phillips LJ, Yuen HP, McGorry P. Risk factors for psychosis in an ultra high-risk group: Psychopathology and clinical features. schizophr Res 2004; 67: 131-42.
88. Frommann I, Pukrop R, Brinkmeyer J, et al. Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early--and additional memory dysfunction in the late--prodromal state. Schizophr Bull 2010; 37(4): 861-73.
89. Wood SJ, Brewer WJ, Koutsouradis P, et al. Cognitive decline following psychosis onset: data from the PACE clinic. Br J Psychiatry Suppl 2007; 51: s52-7.
90. Riecher-Rossler A, Pflueger MO, Aston J, et al. Efficacy of using cognitive status in predicting psychosis: a 7-year follow-up. Biological Psychiatry 2009; 66: 1023-30.
91. Green M. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996; 153: 321-30.
92. Green M, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the right stuff?. Scizophrenia Bulletin 2000; 26: 119-36.
93. Yung AR, Nelson B, Stanford C, Simmons MB, Cosgrave EM, Killackey E. Validation of prodromal criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. Schizophr Res 2008; 105(1-3): 10-7.
94. Phillips LJ, McGorry PD, Yuen HP, et al. Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis. Schizophr Res 2007; 96(1-3): 25-33.
95. Hodge MAR, Siciliano D, Withey P, et al. A randomized controlled trial of cognitive remediation in schizophrenia. Schizophr Bull 2010; 36(2): 419-27.